Vishal Toprani

Vishal Toprani

Pfizer Inc. - New York / United States
Natural Sciences / Biological Science
AD Scientific Index ID: 4544848
-
person_outline Vishal Toprani's MOST POPULAR ARTICLES
1-) Effects of protein conformation, apparent solubility, and protein–protein interactions on the rates and mechanisms of aggregation for an IgG1Monoclonal antibodyC Kalonia, V Toprani, R Toth, N Wahome, I Gabel, CR Middaugh, ...The Journal of Physical Chemistry B 120 (29), 7062-7075, 2016482016
2-) Analytical comparability assessments of 5 recombinant CRM197 proteins from different manufacturers and expression systemsJM Hickey, VM Toprani, K Kaur, RPN Mishra, A Goel, N Oganesyan, ...Journal of pharmaceutical sciences 107 (7), 1806-1819, 2018332018
3-) A micro–polyethylene glycol precipitation assay as a relative solubility screening tool for monoclonal antibody design and formulation developmentVM Toprani, SB Joshi, LA Kueltzo, RM Schwartz, CR Middaugh, ...Journal of Pharmaceutical Sciences 105 (8), 2319-2327, 2016312016
4-) Correlating the impact of well-defined oligosaccharide structures on physical stability profiles of IgG1-Fc glycoformsAS More, VM Toprani, SZ Okbazghi, JH Kim, SB Joshi, CR Middaugh, ...Journal of Pharmaceutical Sciences 105 (2), 588-601, 2016332016
5-) Development of a candidate stabilizing formulation for bulk storage of a double mutant heat labile toxin (dmLT) protein based adjuvantVM Toprani, N Sahni, JM Hickey, GA Robertson, CR Middaugh, SB Joshi, ...Vaccine 35 (41), 5471-5480, 2017192017